184 related articles for article (PubMed ID: 33599887)
1. Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review.
Tier HL; Balogh EA; Bashyam AM; Fleischer AB; Spergel JM; Masicampo EJ; Kammrath LK; Strowd LC; Feldman SR
Dermatol Ther (Heidelb); 2021 Apr; 11(2):415-431. PubMed ID: 33599887
[TBL] [Abstract][Full Text] [Related]
2. Physicians' perceptions of an eczema action plan for atopic dermatitis.
Ntuen E; Taylor SL; Kinney M; O'Neill JL; Krowchuk DP; Feldman SR
J Dermatolog Treat; 2010 Jan; 21(1):28-33. PubMed ID: 19968578
[TBL] [Abstract][Full Text] [Related]
3. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
[TBL] [Abstract][Full Text] [Related]
4. Development and Evaluation of an Atopic Dermatitis Care Plan for Providers.
Utley C; Gold MH; Hall M
J Drugs Dermatol; 2020 Oct; 19(10):950-955. PubMed ID: 33026765
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
6. Factors contributing to poor treatment outcomes in childhood atopic dermatitis.
Sokolova A; Smith SD
Australas J Dermatol; 2015 Nov; 56(4):252-7. PubMed ID: 25817780
[TBL] [Abstract][Full Text] [Related]
7. Does an Eczema Action Plan Improve Atopic Dermatitis? A Single-Site Randomized Controlled Trial.
Brown J; Weitz NW; Liang A; Stockwell MS; Friedman S
Clin Pediatr (Phila); 2018 Dec; 57(14):1624-1629. PubMed ID: 30141340
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic education in atopic dermatitis: A position paper from the International Eczema Council.
Eichenfield LF; Kusari A; Han AM; Barbarot S; Deleuran M; Lio P; Marcoux D; Nosbaum A; Stalder JF
JAAD Int; 2021 Jun; 3():8-13. PubMed ID: 34409365
[TBL] [Abstract][Full Text] [Related]
9. Patterns of clinical management of atopic dermatitis in infants and toddlers: a survey of three physician specialties in the United States.
Saavedra JM; Boguniewicz M; Chamlin S; Lake A; Nedorost S; Czerkies LA; Patel V; Botteman MF; Horodniceanu EG
J Pediatr; 2013 Dec; 163(6):1747-53. PubMed ID: 23953725
[TBL] [Abstract][Full Text] [Related]
10. Atopic dermatitis: a review of topical treatment options.
Simpson EL
Curr Med Res Opin; 2010 Mar; 26(3):633-40. PubMed ID: 20070141
[TBL] [Abstract][Full Text] [Related]
11. Adherence in Atopic Dermatitis.
Patel N; Feldman SR
Adv Exp Med Biol; 2017; 1027():139-159. PubMed ID: 29063437
[TBL] [Abstract][Full Text] [Related]
12. Interventions to Increase Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review.
Bass AM; Anderson KL; Feldman SR
J Clin Med; 2015 Jan; 4(2):231-42. PubMed ID: 26239125
[TBL] [Abstract][Full Text] [Related]
13. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
14. Dermatologists and allergists have far more experience and use more complex treatment regimens in the treatment of atopic dermatitis than other physicians.
Henderson RL; Fleischer AB; Feldman SR
J Cutan Med Surg; 2001; 5(3):211-6. PubMed ID: 11685667
[TBL] [Abstract][Full Text] [Related]
15. Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience.
Calzavara-Pinton P; Fabbrocini G; Girolomoni G; Matiucci A; Micali G; Musumeci ML; Patruno C; Pellacani G; Rossi MT; Castello M; Stingeni L
G Ital Dermatol Venereol; 2020 Feb; 155(1):8-13. PubMed ID: 31760730
[TBL] [Abstract][Full Text] [Related]
16. Current Management of Moderate-to-Severe Atopic Dermatitis: A Survey of Allergists, Pediatric Allergists and Dermatologists in Korea.
Yum HY; Kim HH; Kim HJ; Kim WK; Lee SY; Li K; Lee DH;
Allergy Asthma Immunol Res; 2018 May; 10(3):253-259. PubMed ID: 29676072
[TBL] [Abstract][Full Text] [Related]
17. Beneficial Effects of Antioxidant Furfuryl Palmitate in Non-pharmacologic Treatments (Prescription Emollient Devices, PEDs) for Atopic Dermatitis and Related Skin Disorders.
Pigatto PD; Diani M
Dermatol Ther (Heidelb); 2018 Sep; 8(3):339-347. PubMed ID: 29790104
[TBL] [Abstract][Full Text] [Related]
18. Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea.
Lee JY; Her Y; Kim CW; Kim SS
Ann Dermatol; 2015 Oct; 27(5):499-506. PubMed ID: 26512163
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology and Management of Mild to Moderate Pediatric Atopic Dermatitis.
Sayaseng KY; Vernon P
J Pediatr Health Care; 2018; 32(2):S2-S12. PubMed ID: 29455854
[TBL] [Abstract][Full Text] [Related]
20. An update on the topical and oral therapy options for treating pediatric atopic dermatitis.
Glines KR; Stiff KM; Freeze M; Cline A; Strowd LC; Feldman SR
Expert Opin Pharmacother; 2019 Apr; 20(5):621-629. PubMed ID: 30601075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
